Income before deduction of interest, taxes and amortization: intercure.co (INCR)

InterCure Ltd. is expanding its pharmacy presence through global partnerships, maintaining high margins via premium brands despite regulatory pressure. Tracking EBITDA fluctuations on GURU.Markets, we note that the 0.00 mark reflects the current state of operating profit. The company's revenues are based on the sale of medical and recreational cannabis products through specialized centers.

INCR intercure.co Operating profit EBITDA (11/23/2025 - 11/11/2026)

InterCure - analytical breakdowns and key metrics (INCR)

- market price and analyst price targets:

Stock Price InterCure Ltd|INCR - Price Target Chart

- company stock exchange capitalization indicators:

Market Value InterCure|INCR - Total Company Value

- book capitalization information:

Accounting Value per Share InterCure|INCR - Book Capitalization|Market Capitalization to Book Value intercure.co|INCR - Aggregate Company Assets

- debt level and financial liquidity data:

- earnings and multiples data:

INCR - Net Income|Projected Future Earnings InterCure Ltd.|INCR - Price to Earnings Ratio|Future Price to Earnings Multiple InterCure Ltd|INCR - PEG Multiple|Company Value to EBITDA InterCure|INCR - Operating profit before deduction of amortization|Earnings per share for the trailing year InterCure|INCR - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last twelve months intercure.co|INCR - Net earnings per share growth this year|Projected earnings per share increase next year InterCure Ltd.

Summary company analytics:InterCure Ltd.

This indicator reflects the actual cash balance from core operations before depreciation and taxes, demonstrating the objective efficiency of business processes. Analysis of the EBITDA chart allows for an assessment of how successfully InterCure Ltd. (INCR) monetizes vertical integration while maintaining moderate dependence on external logistics partners and foreign medical cannabis distributors.

Competitors of InterCure Ltd. (INCR)

Operating profit EBITDA Indivior Corp INDV|COLL - Profit before payment of interest, taxes and amortization|Income before deduction of interest, taxes and amortization CRON (thecronosgroup.com)|Canopy Growth Corporation (CGC) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization High Tide Inc|ACB (Aurora Cannabis, Inc.) - Operating profit EBITDA|Achieve Life Sciences Inc (ACHV) - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Skye Bioscience (SKYE)|anebulo.com - Operating profit before amortization|Nutriband - Operating profit before deduction of amortization|Company profit before taxes, interest and amortization NSRX (Nasus Pharma Ltd.)|IGC Pharma Inc - Operating profit EBITDA|Profit before interest, taxes and amortization MIRA Pharmaceuticals|Flora Growth Corp. (FLGC) - Profit before payment of interest, taxes and amortization|IM Cannabis - Income before deduction of interest, taxes and amortization|ADIL (Adial Pharmaceuticals Inc.) - Operating profit EBITDA|Operating profit before deduction of amortization Artelo (ARTL)|Operating profit before deduction of amortization ENSC (Ensysce Biosciences)|Operating profit EBITDA titanpharm.com (TTNP)|Profit before payment of interest, taxes and amortization Greenlane Holdings GNLN|Income before deduction of interest, taxes and amortization INM|Akanda Corp. - Operating profit EBITDA|Profit before interest, taxes and amortization Enveric Biosciences Inc|BGXX (brightgreen.us) - Operating profit before deduction of amortization|Hempacco Co Inc. - Income before deduction of interest, taxes and amortization